{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:23:30Z","timestamp":1767144210592,"version":"build-2238731810"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,26]],"date-time":"2016-12-26T00:00:00Z","timestamp":1482710400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s15010-016-0973-0","type":"journal-article","created":{"date-parts":[[2016,12,26]],"date-time":"2016-12-26T06:23:00Z","timestamp":1482733380000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel"],"prefix":"10.1007","volume":"45","author":[{"name":"on behalf of the SIMSPe Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ranieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Starnini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Carbonara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Pontali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Panese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Monarca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tullio","family":"Prestileo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Barbarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Babudieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,26]]},"reference":[{"key":"973_CR1","unstructured":"United Nations. 45\/111 Basic principles for the treatment of prisoners, 1990. http:\/\/www.un.org\/documents\/ga\/res\/45\/a45r111.htm . Accessed 10 Jan 2015."},{"key":"973_CR2","unstructured":"Dublin declaration on HIV\/AIDS in prisons in Europe and central Asia, 2004. http:\/\/16889-presscdn-0-48.pagely.netdna-cdn.com\/wp-content\/uploads\/2013\/06\/rep-2004-dublin-declaration-en.pdf . Accessed 29 July 2016."},{"key":"973_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11673-014-9547-y","volume":"11","author":"W Bretschneider","year":"2014","unstructured":"Bretschneider W, Elger BS. Expert perspectives on Western European prison health services: do ageing prisoners received equivalent care? J Bioeth Inq. 2014;11:319\u201332.","journal-title":"J Bioeth Inq"},{"key":"973_CR4","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.4254\/wjh.v7.i21.2323","volume":"7","author":"R Zampino","year":"2015","unstructured":"Zampino R, Coppola N, Sagnelli C, et al. Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment. World J Hepatol. 2015;7:2323\u201330.","journal-title":"World J Hepatol"},{"key":"973_CR5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.dld.2010.12.004","volume":"43","author":"PL Almasio","year":"2011","unstructured":"Almasio PL, Babudieri S, Barbarini G, et al. Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates). Dig Liver Dis. 2011;43:589\u201395.","journal-title":"Dig Liver Dis"},{"key":"973_CR6","unstructured":"Thematic report: prisoners monitoring implementation of the dublin d claration on partnership to fight HIV\/AIDS in Europe and Central Asia: 2012 Progress, 2013. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/dublin-declaration-monitoring-report-prisoners-october-2013.pdf . Accessed 29 July 2016."},{"key":"973_CR7","doi-asserted-by":"publisher","unstructured":"Dolan K, Wirtz AL, Moazen B, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016. doi: 10.1016\/S0140-6736(16)30466-4 (Epub ahead of print).","DOI":"10.1016\/S0140-6736(16)30466-4"},{"key":"973_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12879-016-1601-4","volume":"16","author":"A Jaquet","year":"2016","unstructured":"Jaquet A, Wandeler G, Tine J, et al. HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa. BMC Infect Dis. 2016;16:249.","journal-title":"BMC Infect Dis"},{"key":"973_CR9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.puhe.2005.03.017","volume":"120","author":"G Niveau","year":"2006","unstructured":"Niveau G. Prevention of infectious disease transmission in correctional settings: a review. Public Health. 2006;120:33\u201341.","journal-title":"Public Health"},{"key":"973_CR10","unstructured":"Jurgens R. 2009-WHO Technical paper. Geneva, pp. 13\u201372."},{"key":"973_CR11","unstructured":"Neff MJ, CDC. CDC updates guidelines for prevention and control of infections with hepatitis viruses in correctional settings. Am Fam Physician. 2003;67:2620, 2622, 2625."},{"key":"973_CR12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/1756283X15587481","volume":"8","author":"BP Lam","year":"2015","unstructured":"Lam BP, Jeffers T, Younoszai Z, et al. The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment. Ther Adv Gastroenterol. 2015;8:298\u2013312.","journal-title":"Ther Adv Gastroenterol"},{"key":"973_CR13","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(16)00619-X","volume":"387","author":"J Csete","year":"2016","unstructured":"Csete J, Kamarulzaman A, Kazatchkine M, et al. Public health and international drug policy. Lancet. 2016;387:1427\u201380.","journal-title":"Lancet"},{"key":"973_CR14","unstructured":"Department US, of Justice. Key facts at a glance. Correctional populations, 1980\u20132000. 2003."},{"key":"973_CR15","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/jech.2009.090662","volume":"63","author":"IA Binswanger","year":"2009","unstructured":"Binswanger IA, Krueger PM, Steiner JF. Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population. J Epidemiol Commun Health. 2009;63:912\u20139.","journal-title":"J Epidemiol Commun Health"},{"key":"973_CR16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ypmed.2003.11.020","volume":"38","author":"J Baillargeon","year":"2004","unstructured":"Baillargeon J, Black SA, Leach CT, et al. The infectious disease profile of Texas prison inmates. Prev Med. 2004;38:607\u201312.","journal-title":"Prev Med"},{"key":"973_CR17","first-page":"2142","volume":"16","author":"E Sagnelli","year":"2012","unstructured":"Sagnelli E, Starnini G, Sagnelli C, et al. Simspe Group. Blood born viral infections, sexually transmitted diseases and latent tuberculosis in Italian prisons: a preliminary report of a large multicenter study. Eur Rev Med Pharmacol Sci. 2012;16:2142\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"973_CR18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijlp.2015.03.011","volume":"41","author":"M Piselli","year":"2015","unstructured":"Piselli M, Attademo L, Garinella R, et al. Psychiatric needs of male prison inmates in Italy. Int J Law Psychiatry. 2015;41:82\u20138.","journal-title":"Int J Law Psychiatry"},{"key":"973_CR19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijlp.2009.01.006","volume":"32","author":"M Piselli","year":"2009","unstructured":"Piselli M, Elisei S, Murgia N, et al. Co-occurring psychiatric and substance use disorders among male detainees in Italy. Int J Law Psychiatry. 2009;32:101\u20137.","journal-title":"Int J Law Psychiatry"},{"key":"973_CR20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1078345810366867","volume":"16","author":"M Esposito","year":"2010","unstructured":"Esposito M. The health of Italian prison inmates today: a critical approach. J Correct Health Care. 2010;16:230\u20138.","journal-title":"J Correct Health Care"},{"key":"973_CR21","unstructured":"Italian Ministry of Justice, 2014. https:\/\/www.giustizia.it\/giustizia\/it\/mg_1_14_1.wp?facetNode_1=1_5_31&facetNode_4=0_2_10_1&facetNode_3=0_2_10&facetNode_2=0_2&previsiousPage=mg_1_14&contentId=SST613888 . Accessed 20 Aug 2016."},{"key":"973_CR22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.bdj.2014.646","volume":"217","author":"E Heidari","year":"2014","unstructured":"Heidari E, Dickinson C, Newton T. Multidisciplinary team working in an adult male prison establishment in the UK. Br Dent J. 2014;217:117\u201321.","journal-title":"Br Dent J"},{"key":"973_CR23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(10)61053-7","volume":"377","author":"S Fazel","year":"2011","unstructured":"Fazel S, Baillargeon J. The health of prisoners. Lancet. 2011;377:956\u201365.","journal-title":"Lancet"},{"key":"973_CR24","unstructured":"http:\/\/www.epatitec.info\/default.asp?id=743 . Accessed 30 Oct 2016."},{"key":"973_CR25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jmv.20375","volume":"76","author":"S Babudieri","year":"2005","unstructured":"Babudieri S, Longo B, Sarmati L, et al. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol. 2005;76:311\u20137.","journal-title":"J Med Virol"},{"key":"973_CR26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1186\/1471-2458-13-981","volume":"13","author":"M Brandolini","year":"2013","unstructured":"Brandolini M, Novati S, De Silvestri A, et al. Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting. BMC Public Health. 2013;13:981.","journal-title":"BMC Public Health"},{"key":"973_CR27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1108\/IJPH-07-2015-0022","volume":"12","author":"E Pontali","year":"2016","unstructured":"Pontali E, Bobbio N, Zaccardi M, Urciuoli R. Blood-borne viral co-infections among human immunodeficiency virus-infected inmates. Int J Prison Health. 2016;12:88\u201397.","journal-title":"Int J Prison Health"},{"key":"973_CR28","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1186\/s12879-015-1301-5","volume":"15","author":"R Monarca","year":"2015","unstructured":"Monarca R, Madeddu G, Ranieri R, et al. SIMSPe\u2013SIMIT Group.HIV treatment and care among Italian inmates: a one-month point survey. BMC Infect Dis. 2015;15:562.","journal-title":"BMC Infect Dis"},{"key":"973_CR29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/aid.2007.0240","volume":"24","author":"I Maida","year":"2008","unstructured":"Maida I, Rios MJ, Perez-saleme L, et al. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era. AIDS Res Hum Retroviruses. 2008;24:679\u201383.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"973_CR30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jurban\/jth085","volume":"81","author":"L Solomon","year":"2004","unstructured":"Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health. 2004;81:25\u201337.","journal-title":"J Urban Health"},{"key":"973_CR31","doi-asserted-by":"crossref","unstructured":"Semaille C, Le Strat Y, Chiron E, Prevacar Group, et al. Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy. Euro Surveill. 2013;18.","DOI":"10.2807\/1560-7917.ES2013.18.28.20524"},{"key":"973_CR32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3855\/jidc.517","volume":"4","author":"Z Mahfoud","year":"2010","unstructured":"Mahfoud Z, Kassak K, Kreidieh K, et al. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon. J Infect Dev Ctries. 2010;4:144\u20139.","journal-title":"J Infect Dev Ctries"},{"key":"973_CR33","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/hep.26991","volume":"59","author":"T Santantonio","year":"2014","unstructured":"Santantonio T, Fasano M, Sagnelli E, Acute Hepatitis C Study Group, et al. Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus 12-week course of pegylated interferon alpha-2b alone or with ribavirin. Hepatology. 2014;59:2101\u20139.","journal-title":"Hepatology"},{"key":"973_CR34","doi-asserted-by":"publisher","unstructured":"Foschi A, Casana M, Radice A, et al. CORRESPONDENCE: Hepatitis C management in prisons: An insight into daily clinical practice in three major Italian Correctional Houses. Hepatology. 2016. doi: 10.1002\/hep.28609 (Epub ahead of print).","DOI":"10.1002\/hep.28609"},{"key":"973_CR35","doi-asserted-by":"crossref","unstructured":"Aspinall EJ, Mitchell W, Schofield J, et al. A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy. J Viral Hepat. 2016;23:1009\u20131016.","DOI":"10.1111\/jvh.12580"},{"key":"973_CR36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2893.2008.01008.x","volume":"15","author":"AJ Sutton","year":"2008","unstructured":"Sutton AJ, Edmunds WJ, Sweeting MJ, Gill ON. The cost-effectiveness of screening and treatment for hepatitis C in prisons in England and Wales: a cost-utility analysis. J Viral Hepat. 2008;15:797\u2013808.","journal-title":"J Viral Hepat"},{"key":"973_CR37","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/hep.26113","volume":"57","author":"AY Kim","year":"2013","unstructured":"Kim AY, Nagami EH, Birch CE, et al. A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users. Hepatology. 2013;57:944\u201352.","journal-title":"Hepatology"},{"key":"973_CR38","unstructured":"The alcohol use disorders identification test guidelines for use in primary care, 2001. http:\/\/www.talkingalcohol.com\/files\/pdfs\/WHO_audit.pdf . Accessed 30 Oct 2016."},{"key":"973_CR39","unstructured":"Starnini ICAR 2016."},{"key":"973_CR40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3201\/eid1804.111016","volume":"18","author":"S Babudieri","year":"2012","unstructured":"Babudieri S, Soddu A, Murino M, et al. Tuberculosis screening before anti-hepatitis C virus therapy in prisons. Emerg Infect Dis. 2012;18:689\u201391.","journal-title":"Emerg Infect Dis"},{"key":"973_CR41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.drugalcdep.2016.05.012","volume":"165","author":"A Weir","year":"2016","unstructured":"Weir A, McLeod A, Innes H, et al. Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs. Drug Alcohol Depend. 2016;165:53\u201360.","journal-title":"Drug Alcohol Depend"},{"key":"973_CR42","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jhep.2015.03.029","volume":"63","author":"J Lalezari","year":"2015","unstructured":"Lalezari J, Sullivan JG, Varunok P, et al. Ombitasvir\/paritaprevir\/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine. J Hepatol. 2015;63:364\u20139.","journal-title":"J Hepatol"},{"key":"973_CR43","unstructured":"Agenzia Italiana del Farmaco, 2016. http:\/\/www.agenziafarmaco.gov.it\/it\/content\/algoritmi-terapeutici . Accessed 20 Aug 2016."},{"key":"973_CR44","doi-asserted-by":"crossref","unstructured":"Martin NK, Hickman M, Miners A, et al. Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons. BMJ Open. 2013;3:e003153.","DOI":"10.1136\/bmjopen-2013-003153"},{"key":"973_CR45","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/hep.28497","volume":"63","author":"NK Martin","year":"2016","unstructured":"Martin NK, Vickerman P, Brew IF, et al. Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis. Hepatology. 2016;63:1796\u2013808.","journal-title":"Hepatology"},{"key":"973_CR46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7326\/M15-0617","volume":"164","author":"T He","year":"2016","unstructured":"He T, Li K, Roberts MS, et al. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons. Ann Intern Med. 2016;164:84\u201392.","journal-title":"Ann Intern Med"},{"key":"973_CR47","doi-asserted-by":"crossref","unstructured":"Darke J, Cresswell T, McPherson S, Hamoodi A. Hepatitis C in a prison in the North East of England: what is the economic impact of the universal offer of testing and emergent medications? J Public Health (Oxf). 2015 (Epub ahead of print).","DOI":"10.1093\/pubmed\/fdv178"}],"updated-by":[{"DOI":"10.1007\/s15010-017-0983-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T00:00:00Z","timestamp":1486512000000}}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-016-0973-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-016-0973-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-016-0973-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T08:27:25Z","timestamp":1718958445000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-016-0973-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,26]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1007\/s15010-016-0973-0","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,26]]}}}